Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...
主要な著者: | , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Taylor & Francis Group
2017-04-01
|
シリーズ: | Expert Review of Vaccines |
主題: | |
オンライン・アクセス: | http://dx.doi.org/10.1080/14760584.2017.1294068 |